Detalhe da pesquisa
1.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol;
93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429340
2.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol;
93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429343
3.
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
J Virol;
91(9)2017 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28202751
4.
DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.
J Gen Virol;
98(8): 2143-2155, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28758637
5.
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol;
90(8): 4133-4149, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26865719
6.
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
J Virol;
93(21)2019 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31615930
7.
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
J Gen Virol;
92(Pt 1): 128-40, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21169215
8.
Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
Biochem Biophys Res Commun;
366(1): 29-35, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18036339
9.
HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.
Biochem Biophys Res Commun;
370(1): 22-6, 2008 May 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18329382
10.
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
PLoS One;
13(11): e0207794, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30500852
11.
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
PLoS One;
11(4): e0153484, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27077384
12.
Nedd4-mediated increase in HIV-1 Gag and Env proteins and immunity following DNA-vaccination of BALB/c mice.
PLoS One;
9(3): e91267, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24614057
13.
Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1.
Virology;
432(1): 173-83, 2012 Oct 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22769870
14.
Characterization of a SHIV162P3 variant evolved in an infected rhesus macaque with persistent plasma viremia.
Virus Res;
151(2): 229-34, 2010 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20417670
15.
Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.
J Virol Methods;
163(2): 287-94, 2010 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19878696
16.
Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
Virology;
386(1): 102-8, 2009 Mar 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19195672
17.
Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques.
J Med Primatol;
37 Suppl 2: 13-23, 2008 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19187427
18.
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.
Proc Natl Acad Sci U S A;
104(44): 17477-82, 2007 Oct 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17956985
19.
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
Virology;
366(1): 197-211, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17499328